See the Full Picture.
Published loading...Updated

XiFin Study Shows Bigger Role Seen for Specialty Rx

Summary by CDR – Chain Drug Review
SAN DIEGO — XiFin Inc. shared findings from its inaugural specialty pharmacy survey at Asembia’s AXS25 industry summit. The survey finds a sector poised to step into a more significant role in addressing patient care needs, with a focus on managing chronic conditions that require increasingly complex medication regimens.David Pope“As the population continues to age and the burden of chronic conditions grows, the demand for specialty pharmacy ser…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CDR – Chain Drug Review broke the news in on Monday, June 9, 2025.
Sources are mostly out of (0)